Screener
Rallybio Corporation RLYB Q3 2025 earnings
Reported November 6, 2025 · Before market open
Revenue$212.0KBeat by $145.3K
EPS-$0.14Beat by $0.11
Revenue estimate$66.7K
EPS estimate-$0.25
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$1.44
Versus estimates
Revenue
Q1 2026$212.0KIn lineQ4 2025$222.0KBeat by $122.0K
Q3 2025$212.0KBeat by $145.3K
Q2 2025$212.0KBeat by $145.3KQ1 2025$212.0KDiluted EPS
FAQ
- When did Rallybio Corporation report Q3 2025 earnings?
- Rallybio Corporation (RLYB) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Rallybio Corporation's Q3 2025 revenue and EPS?
- Rallybio Corporation reported revenue of $212.0K and eps of $-0.14 for Q3 2025.
- Did Rallybio Corporation beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $66.7K by $145.3K. EPS beat the consensus estimate of $-0.25 by $0.11.
- How did Rallybio Corporation's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 29.1% from $299.0K a year earlier and eps grew 46.2% from $-0.26.
- Where can I find Rallybio Corporation's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001739410-25-000131) and the 10-Q periodic report (0001739410-25-000132) directly on SEC EDGAR. The filing index links above go to sec.gov.
